Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 27, 2021	Nov. 28, 2020
Operating Activities
Net earnings	$ 19,759	$ 57,807
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	38,353	38,000
Share-based compensation	4,807	6,163
Deferred income taxes	(5,412)	5,012
Asset impairment	16,638	0
Gain on disposal of assets	(1,250)	(19,346)
Noncash lease expense	9,302	9,531
Other, net	3,009	(69)
Changes in operating assets and liabilities:
Receivables	6,443	24,153
Inventories	(2,657)	(2,722)
Costs and earnings on contracts in excess of billings	(1,168)	(44,501)
Accounts payable and accrued expenses	5,440	(43,915)
Billings on contracts in excess of costs and earnings	(4,474)	(6,981)
Refundable and accrued income taxes	5,255	12,424
Operating lease liability	(9,387)	(9,168)
Other	(703)	5,122
Net cash provided by operating activities	86,291	120,512
Investing Activities
Capital expenditures	(13,070)	(17,116)
Proceeds from sales of property, plant and equipment	1,347	23,724
Other	76	(1,090)
Net cash (used) provided by investing activities	(11,647)	5,518
Financing Activities
Borrowings on line of credit	0	193,332
Repayments on debt	(2,000)	(5,400)
Payments on line of credit	0	237,500
Proceeds from exercise of stock options	4,115	1,456
Repurchase and retirement of common stock	29,164	20,731
Dividends paid	(15,050)	(14,546)
Other	(1,895)	(2,309)
Net cash used by financing activities	(43,994)	(85,698)
Increase in cash and cash equivalents	30,650	40,332
Effect of exchange rates on cash	345	129
Cash, cash equivalents and restricted cash at beginning of year	47,277	14,952
Cash, cash equivalents and restricted cash at end of period	78,272	55,413
Noncash Activity
Capital expenditures in accounts payable	$ 1,095	$ 684